Recent PALI News
- Palisade Bio Appoints Margery Fischbein to its Board of Directors • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules • GlobeNewswire Inc. • 05/07/2024 11:30:00 AM
- Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules • GlobeNewswire Inc. • 05/02/2024 12:30:00 PM
- Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS) • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool • GlobeNewswire Inc. • 04/16/2024 12:30:00 PM
- Palisade Bio to Participate in the Virtual Investor Lunch Break Event • GlobeNewswire Inc. • 04/11/2024 01:15:00 PM
- Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™ • GlobeNewswire Inc. • 04/10/2024 12:15:00 PM
- Palisade Bio Announces 1-for-15 Reverse Stock Split • GlobeNewswire Inc. • 04/03/2024 09:30:00 PM
- Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:35:16 PM
- Palisade Bio to Present at Digestive Disease Week (DDW) 2024 • GlobeNewswire Inc. • 02/15/2024 01:35:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:54:03 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:10:04 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:38:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 08:08:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 08:08:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 08:08:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 08:08:36 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/13/2024 07:51:09 PM
- Palisade Bio Provides Corporate Update and Reiterates Guidance • GlobeNewswire Inc. • 02/13/2024 01:35:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:03:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:38:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:37:40 PM
- Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board Members • GlobeNewswire Inc. • 02/08/2024 07:40:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM